Could traditional Chinese medicine hold a key to treating life-threatening cardiac disease?
In a clinical trial, patients with acute STEMI who took TCM compound Tongxinluo showed a lower risk of another heart attack. Further study is needed, experts say, to identify the specific active ingredient – which could help advance future treatments.
A clinical trial in China has found that a traditional Chinese medicine compound significantly reduced cardiac death among people with a serious type of heart attack.
Acute ST-elevation myocardial infarction (STEMI) is a life-threatening condition that carries high risks of in-hospital mortality and recurrent cardiovascular events, but there have been no major advances in therapeutics in more than a decade.
Now a team of scientists in China and the United States have carried out the first large clinical trial to evaluate the efficacy and safety of a potentially cardioprotective Chinese medicine compound as an adjunctive treatment for patients with acute STEMI.
“Oral administration of Tongxinluo for 12 months, compared with placebo, significantly reduced … major adverse cardiac and cerebrovascular events, with a significant reduction in cardiac death [within 30 days]. These benefits persisted within one year,” the team said.
The researchers, from the state key laboratories of cardiovascular disease and component-based Chinese medicine, hospitals in Beijing, Guangdong, Henan, Jiangsu, Liaoning, Shandong and Xinjiang, as well as the University of Texas Southwestern Medical Centre, published the clinical trial results in the peer-reviewed Journal of the American Medical Association (JAMA).
Tongxinluo, a compound of powders and extracts from several plant and insect products, means “opening the network of the heart” in Chinese. The patent medicine is developed and produced by Shijiazhuang Yiling Pharmaceutical.
In 1996, China approved it for angina pectoris – chest pain due to coronary heart disease – and ischemic stroke, which happens when a vessel supplying blood to the brain is obstructed. The product can be bought online as a dietary supplement.
But while it has shown promise in in-vitro, animal and human studies, it “has not been rigorously evaluated in large randomised clinical trials”, according to the study.
In the trial, nearly 3,800 patients with STEMI were recruited across 124 Chinese hospitals in 2019 and 2020 to receive either the Chinese medicine capsule or a placebo for 12 months, in addition to standard treatments.
In the first 30 days, events including cardiac death, recurrent heart attack, emergent coronary revascularisation (treatments to restore blood flow to parts of the heart) and stroke were experienced by 5.2 per cent of the placebo group, compared with 3.4 per cent of the Tongxinluo group.
The cardiac death rate was 4.2 per cent in the placebo group and 3 per cent in the Tongxinluo group.
And after one year, the results were 8.3 per cent versus 5.3 per cent for cardiac events and 6.1 per cent versus 4.5 per cent for cardiac deaths.
The team said further research was needed to determine which of Tongxinluo’s active ingredients were contributing to the positive results, as well as their exact mechanisms of action.
In an accompanying editorial also published by JAMA, Richard Bach, a professor of medicine at Washington University in St Louis, agreed that isolating and testing the specific active ingredients of Tongxinluo could help contribute to the next advance in the treatment of acute STEMI.
“Given that Tongxinluo is a mixture of multiple plant and animal products, the active ingredients and mechanisms of action are unknown,” said Bach, who also serves as the medical director of the cardiac intensive care unit at Barnes-Jewish Hospital in St Louis.
He added that one or more clinical trials would be needed to understand how Tongxinluo might affect outcomes in a Western population.
via scmp
Original article by admin, if reproduced, please cite the source as: https://www.tcmha.com/tcmnews/could-traditional-chinese-medicine-hold-a-key-to-treating-life-threatening-cardiac-disease.html
相关推荐
-
TCM effective in treating respiratory, lung diseases, experts say
Regarding interstitial lung diseases — illnesses that cause scarring of the lungs, Zhang said TCM medicines can help lower dosage of hormone, alleviate side effects of hormone and enhance immunity of patients.
-
Long Covid: how traditional Chinese medicine can help with symptoms from fatigue and persistent cough to erectile dysfunction
More people are turning to traditional Chinese medicine to recover from long Covid, a Hong Kong-based practitioner says. While there is no specific herb to treat long Covid – each patient is assessed according to their unique presentation – there are some broad guidelines.
-
Shanghai launches digital TCM innovation center to benefit patients across the world with quality TCM resources
Shanghai has launched a digital traditional Chinese medicine (TCM) innovation center, vowing to benefit patients from across the world with quality TCM treatment resources. The project led by Shanghai University of Traditional Chinese Medicine consists of three parts: the big data center, the internet medical center and the exhibition center of TCM. Based on the health record database of the Shanghai Municipal Health Commission combined with patients’ data from the university and its affiliated hospitals, the big data center will integrate scientific research, medicine research and development, and the inheritance…
-
Traditional medicines now available as temperatures drop
With Sunday marking the beginning of this year’s 17th solar term, hanlu, or cold dew, which in the Chinese traditional calendar indicates falling temperatures, the annual gaofang season opened in Shanghai.
-
Traditional Chinese Medicine indispensable for COVID treatment
He said the World Health Organization has affirmed the effectiveness and safety of traditional Chinese medicine in the treatment of COVID-19 at an expert assessment meeting.
-
Traditional Chinese Medicine Shows Promise in Treating Lung Cancer
The natural compound berberine, which is present in plants like goldenseal and barberry, has promise for the treatment of lung diseases.
-
China Exports Its Traditional Medicine to Africa
In Kenya, Hing Pal Singh is one of the patients who visits the Oriental Chinese Herbal Clinic in the capital, Nairobi. Singh is 85 years old. He has had problems with his back for five years. Singh is now trying herbal treatments. These are medicines made from plants. “There is a slight difference,” Singh said. “… It’s only a week now. It will take at least another 12 to 15 sessions. Then we see how it goes.” A 2020 study from the Beijing research group Development Reimagined, said that traditional…
-
Traditional Chinese Medicine can’t stop you getting Covid-19, says renowned expert Zhong Nanshan
Zhong has long been an advocate for TCM but he told a conference that currently no drug has been proven to prevent people becoming infected by the virus.His comments follow a controversy after a leading online health platform was suspended soon after questioning the benefits of traditional treatments.
-
US embraces traditional Chinese medicine
TCM includes acupuncture, cupping, pain moxibustion (a form of heat therapy), herbal medicine, nutrition, tuina massage (used with modern medical techniques to treat a range of conditions), and exercise such as tai chi and qigong, which combine movement and meditation.
-
From flu vaccines to TCM and breast cancer: Experts advise how to take charge of your health in 2023
In the latest series of One FM Good Morning podcasts, medical experts from Parkway Shenton and Parkway East Hospital shed light on some of the most discussed health topics in Singapore
